<DOC>
	<DOC>NCT02821156</DOC>
	<brief_summary>This is a prospective, observational, multicenter study conducted during 1 year in adult and paediatric intensive care units equipped with the EZ-KINOX™ system. A maximum of 250 patients (newborns to adults, suffering from Pulmonary Arterial Hypertension (PAH) associated with cardiac surgery or Persistent Pulmonary Hypertension in the Newborn (PPHN) receiving iNO through the integrated delivery and monitoring EZ-KINOX™ system was planned to be included. The study is strictly non-interventional with the aim of describing current practices and therefore did not affect the patient usual management.</brief_summary>
	<brief_title>Study on the Use of Inhaled NO (iNO)</brief_title>
	<detailed_description>This study is intended to describe daily practice and therefore, there is not a standardized protocol but only patient-based and site-based questionnaires.</detailed_description>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Newborn &gt; or = to 34 weeks gestational age suffering from hypoxic respiratory failure with pulmonary hypertension (France only) or patient presenting postoperative pulmonary hypertension associated with cardiac surgery (France and Belgium) · Patient treated with iNO delivered with EZKINOX™ Newborn dependent on a righttoleft shunt or with a "malignant" leftright arterial canal Newborn with Glucose6Phosphate Dehydrogenase (G6PD) deficiency.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>